Chris Buyse
Director/Board Member at INVENTIVA
Net worth: - $ as of 2024-04-29
Network origin in Chris Buyse first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
21
| Extinct | Pharmaceuticals: Major | 21 |
21
| Public Company | Biotechnology | 21 |
17
| Public Company | Pharmaceuticals: Major | 17 |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.
15
| Subsidiary | Biotechnology | 15 |
| Public Company | Biotechnology | 14 | |
University of Antwerp
12
| College/University | Other Consumer Services | 12 |
| Public Company | Pharmaceuticals: Major | 11 | |
EyeD Pharma SA
 EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium.
8
| Holding Company | Medical Specialties | 8 |
Fund+
 Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium.
7
| Private Company | Investment Managers | 7 |
Cellaïon SA
 Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation.
5
| Holding Company | Biotechnology | 5 |
Bio-Incubator Leuven
 Bio-Incubator Leuven Real Estate DevelopmentFinance Bio-Incubator Leuven is a dynamic and innovative environment that provides lab space and support to R&D-intensive life sciences companies. The private company offers customizable modules that can be modified to meet the specific requirements of each client. The company is based in Leuven, Belgium. Leuven's knowledge institutes, including KU Leuven, University Hospitals Leuven, VIB, and IMEC, generate a huge outflow of knowledge that entails a myriad of innovative ideas for new and existing companies. The CEO of the Belgian company is Michaël de Blauwe.
5
| Private Company | Real Estate Development | 5 |
| Public Company | Packaged Software | 4 | |
Pinnacle Investments NV
3
| Private Company | 3 | |
Fondation Francqui
2
| Private Company | 2 | |
Creabuild NV
 Creabuild NV Miscellaneous Commercial ServicesCommercial Services Creabuild NV provides consulting services. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2005. The CEO is Stéphane Vandervelde.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Sofia BVBA
 Sofia BVBA Wireless TelecommunicationsCommunications Sofia BV provides wireless telecommunication services. The private company is based in Knokke-Heist, Belgium. The CEOs are Ann Dendoncker, Chris Buyse, Pieter-Jan Buyse. The Belgian company was founded in 1999.
2
| Private Company | Wireless Telecommunications | 2 |
Life Sciences Research Partners VZW
 Life Sciences Research Partners VZW Investment Trusts/Mutual FundsMiscellaneous Life Sciences Research Partners VZW functions as a foundation or endowment. The non-profit company is based in Leuven, Belgium. The Belgian company was founded by Désiré Collen.
2
| Non-Profit Organization | Investment Trusts/Mutual Funds | 2 |
Pienter-Jan BV
 Pienter-Jan BV Miscellaneous Commercial ServicesCommercial Services Pienter-Jan BV is a Belgian company that provides business and management consulting services. The private company is based in Brasschaat, Belgium. The CEO of the company is Ann Dendoncker.
1
| Private Company | Miscellaneous Commercial Services | 1 |
| Public Company | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Chris Buyse via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GOLDEN QUEEN MINING CONSOLIDATED LTD. | Precious Metals | Director/Board Member Chief Executive Officer | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| TIGENIX NV | Medical Specialties | Chairman Director of Finance/CFO Director/Board Member | |
| DELHAIZE GROUP | Food Retail | Corporate Officer/Principal Chief Executive Officer | |
Docpharma NV
 Docpharma NV Pharmaceuticals: MajorHealth Technology Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member | |
Laboratoires Fournier SAS
 Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Laboratoires Fournier SAS manufactures pharmaceutical preparations. The company was founded on July 10, 2007 and is headquartered in Rungis, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BNP Paribas Fortis Private Equity Belgium NV
 BNP Paribas Fortis Private Equity Belgium NV Investment ManagersFinance BNP Paribas Fortis Private Equity Belgium NV is a Private Equity/Venture Capital firm, a subsidiary of BNP Paribas Fortis SA/NV founded in 1981. BNP Paribas Fortis Private Equity Belgium NV is headquartered in Brussels. | Investment Managers | Private Equity Investor Director/Board Member | |
| BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member General Counsel | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| North Dakota State University | College/University | Doctorate Degree Undergraduate Degree | |
| INSEAD | College/University | Undergraduate Degree Masters Business Admin | |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member President Director of Finance/CFO | |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Ghent University | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| Université Libre de Bruxelles | College/University | Undergraduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Université Paris Dauphine-PSL | College/University | Undergraduate Degree Graduate Degree | |
| University College Cork | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ESSEC Business School | College/University | Chief Executive Officer Undergraduate Degree | |
| Vrije Universiteit Brussel | College/University | Graduate Degree Corporate Officer/Principal | |
| Vlerick Leuven Gent Management School | College/University | Masters Business Admin Masters Business Admin | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Noshaq SA
 Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director of Finance/CFO Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree Undergraduate Degree Chairman Graduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Chairman Chairman Chairman | |
Abbott Laboratories Co.
 Abbott Laboratories Co. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Co. provides health care services. The firm conducts research and manufactures products for human health through every life stage. Its products include nutrition, diagnostics, vascular and diabetes care. The company is headquartered in Saint-Laurent, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
HYBRID Software Development SA
 HYBRID Software Development SA Packaged SoftwareTechnology Services HYBRID Software Development SA engages in the development of XML paper specification software under NiXPS platform. Its products include NiXPS Library and NiXPS Edit applications. The company was founded by Nick de Roeck on May 31, 2007 and is headquartered in Lochristi, Belgium. | Packaged Software | Chief Executive Officer Director/Board Member | |
Uteron Pharma SA
 Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Equipment/Instruments | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Hybrid Software, Inc.
 Hybrid Software, Inc. Packaged SoftwareTechnology Services Hybrid Software, Inc. provides software solutions for the commercial printing, label and packaging and wide format printing markets. Its products include CLOUDFLOW, FRONTDESK, FACELIFT and PIPELINE. The company was founded by Mike Rottenborn in 2007 and is headquartered in Langhorne, PA. | Packaged Software | Chairman Director/Board Member | |
| Solvay Business School of Economics & Management | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree | |
| LYSOGENE | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| Magenta Tree BV | Corporate Officer/Principal Founder | ||
KiOmed Pharma SA
 KiOmed Pharma SA Pharmaceuticals: MajorHealth Technology KiOmed Pharma SA develops pharmaceutical products. It offers animal-free, ultrapure chitosan-based breakthrough biomaterials for the development of safer and highly efficient therapeutic medical devices and implants for joint health, ophthalmology, tissue engineering and biosurgery. The company was founded by Francois Blondel and Yves Henrotin in 2015 and is headquartered in Herstal, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Mylan Laboratories SAS
 Mylan Laboratories SAS Pharmaceuticals: MajorHealth Technology Mylan Laboratories SAS operates as a pharmaceutical company. The company is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
| Sise SA | Director/Board Member Director/Board Member | ||
Keyware Smart Card Division NV
 Keyware Smart Card Division NV Finance/Rental/LeasingFinance Part of Keyware Technologies NV, Keyware Smart Card Division NV is a Belgian company that provides electronic payment solutions for all sectors, both online and onsite. The company is based in Zaventem, Belgium. Keyware offers payment solutions that perfectly match businesses, with options for both online and onsite transactions. The company was founded in 1993. | Finance/Rental/Leasing | Director/Board Member Director/Board Member | |
Alter Pharma Group NV
 Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Alter Pharma Group NV manufactures and distributes pharmaceutical products. The company was founded in 2006 and is headquartered in Anderlecht, Belgium. | Pharmaceuticals: Major | Founder Founder | |
Congra Software SARL
 Congra Software SARL Packaged SoftwareTechnology Services Congra Software SARL provides software solutions. The private company is based in Strassen, Luxembourg. | Packaged Software | Chairman Director/Board Member | |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Hyloris Developments SA
 Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Hyloris Developments SA is a Belgian pharmaceutical company that manufactures and sells pharmaceutical products. The private company is based in Liege, Belgium. The company was founded in 2013. The CEO is Stijn van Rompay. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Statistics
International
| Belgium | 30 |
| France | 13 |
| United States | 4 |
| Canada | 3 |
| Switzerland | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 16 |
| Finance | 6 |
| Commercial Services | 5 |
| Technology Services | 4 |
Operational
| Director/Board Member | 457 |
| Corporate Officer/Principal | 146 |
| Chairman | 103 |
| Chief Executive Officer | 83 |
| Independent Dir/Board Member | 59 |
Most connected contacts
| Insiders | |
|---|---|
| James Gale | 45 |
| Stefan Yee | 39 |
| Marc Foidart | 38 |
| Baron Jean Stéphenne | 36 |
| Patrick van Beneden | 28 |
| Guido René van der Schueren | 28 |
| Mounia Chaoui-Roulleau | 27 |
| Staf van Reet | 22 |
| Damian Marron | 21 |
| Landon Clay | 19 |
| Johan Cardoen | 19 |
| Marc Nolet de Brauwere | 19 |
| Jos Sluys | 17 |
| Paul Deleu | 17 |
| Nicolas Jacques Boël | 16 |
- Stock Market
- Insiders
- Chris Buyse
- Company connections